Clinical trial
Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer
NCT01054079
Study timeline
Study start (unknown)2011-09-01Date precision: month
Registry last updated2018-07-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Adenocarcinoma of the Prostateunresolved
Recurrent Prostate Cancerunresolved
Interventions
quality-of-life assessmentPROCEDURE
cinacalcet hydrochlorideDRUG · verified · RxNorm: cinacalcet hydrochloride
Sponsors & collaborators
Wake Forest University Health Scienceslead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01054079 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.